The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TRUCE-02: An open label, single-arm, phase II study of tislelizumab combined with nab-paclitaxel for high-risk non-muscle-invasive urothelial bladder carcinoma.
 
HaiTao Wang
No Relationships to Disclose
 
Hailong Hu
No Relationships to Disclose
 
Yuanjie Niu
No Relationships to Disclose
 
Dawei Tian
No Relationships to Disclose
 
Chong Shen
No Relationships to Disclose
 
La Da
No Relationships to Disclose
 
Zhouliang Wu
No Relationships to Disclose
 
Gangjian Zhao
No Relationships to Disclose
 
Diansheng Zhou
No Relationships to Disclose
 
Yiduo Bai
No Relationships to Disclose
 
Houyuan Chen
No Relationships to Disclose